Back to search

Article

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs

2023-11-08

Abstract excerpt

<title>Abstract</title> <p>The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the gene-drug interaction of <italic>CYP2C9</italic> and <italic>HLA-B</italic> with phenytoin, <italic>HLA-A</italic> and <italic>HLA-B</italic> with carbamazepine and <italic>HLA-B</italic>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b4a899b3-bc20-54d5-8be5-21a3fd1851c5
DOI
10.21203/rs.3.rs-3255043/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugsDOI 10.21203/rs.3.rs-3255043/v1
Select a neighboring publication to make it the new centre.